S000000203 IFB Toxicology Kits.pdf

S000000203 Page 1 of 11

STATE OF ARKANSAS

DEPARTMENT OF TRANSFORMATION AND SHARED SERVICES

OFFICE OF STATE PROCUREMENT

501 Woodlane St., Ste. 220 Little Rock, Arkansas 72201-1023

INVITATION FOR BID

SOLICITATION DOCUMENT

SOLICITATION INFORMATION

Solicitation Number: S000000203 Solicitation Issued: December 15, 2022

Description: Toxicology Kits

Department: Arkansas State Police – AR State Crime Lab

SUBMISSION DEADLINE AND DELIVERY OF RESPONSE DOCUMENTS

Bid Opening Date: January 11, 2023 Bid Opening Time: 1:00 p.m., Central Time

Bid responses for this Invitation for Bid must be submitted through ARBuy, the State’s eProcurement system.

It can be accessed at https://arbuy.arkansas.gov. Bids received after the submission deadline may be rejected as untimely. See section 1.2 for information regarding Live Bid Openings.

TSS OFFICE OF STATE PROCUREMENT CONTACT INFORMATION

TSS OSP Buyer: Julia Shackelford Buyer’s Direct Phone Number: 501-371-6079

Email Address: Julia.shackelford@arkansas.gov TSS OSP’s Main Number: 501-324-9316

TSS OSP

Website:

https://www.transform.ar.gov/procurement/ https://arbuy.arkansas.gov/ https://www.transform.ar.gov/procurement/

S000000203 Page 2 of 11

SECTION 1 – REQUIREMENTS

• Do not provide responses to items in this section unless specifically and expressly required.

1.1 INTRODUCTION

This Invitation for Bid (IFB) is issued by the TSS Office of State Procurement (TSS OSP) on behalf of the Arkansas State Police (ASP) to obtain pricing and a contract for Toxicology Kits for the Arkansas State Crime Lab (ASCL).

Direct all questions, comments, or concerns you may have regarding this solicitation to the TSS Office of State Procurement, not ASP/ASCL.

1.2 LIVE BID OPENING

Use the information below to view the bid opening via Microsoft Teams.

Meeting Link: Click here to join the meeting Meeting ID: 215 524 168 063 Meeting Passcode: 4B7qiz Dial-In Information: +1 501-244-3310,,679834925# United States, Little Rock

1.3 CLARIFICATION OF SOLICITATION

A. Submit any questions requesting clarification of information contained in this Solicitation via the solicitation posting in ARBuy by 10:00 a.m., Central Time on or before January 3, 2023.

1. For each question submitted, Prospective Contractor should reference the specific solicitation item number to which the question refers.

2. Prospective Contractors’ written questions will be consolidated and answered by the State as deemed appropriate. The State’s consolidated written response is anticipated to be posted to the solicitation posting in ARBuy by the close of business on January 4, 2023. If Prospective Contractor questions are unclear or non-substantive in nature, the State may request clarification of a question(s) or decline to answer.

B. The Prospective Contractor should notify the TSS OSP buyer of any term, condition, etc., that precludes the Prospective Contractor from submitting a compliant, Responsive Bid. Prospective Contractors should note that it is the responsibility of the Prospective Contractor to seek resolution of all such issues, including those relating to the terms and conditions of the contract, prior to the submission of a bid.

C. Prospective Contractors may contact the TSS OSP buyer with non-substantive questions at any time prior to the bid opening.

D. An oral statement by TSS OSP will not be part of any contract resulting from this solicitation and may not reasonably be relied on by any Prospective Contractor as an aid to interpretation unless it is reduced to writing and expressly adopted by TSS OSP.

1.4 DEFINITION OF TERMS

A. Unless otherwise defined herein, all terms defined in Arkansas Procurement Law have the same meaning herein.

B. The terms “Invitation For Bid,” “IFB,” and “Solicitation” are used synonymously in this document.

C. “Prospective Contractor” means a responsible bidder who submits a Responsive Bid in response to this solicitation.

https://teams.microsoft.com/l/meetup-join/19%3ameeting_NTNjMzJhZWQtOGFlMy00ZGE3LWJlMjMtZGU4NGZhMmQ0MDhl%40thread.v2/0?context=%7b%22Tid%22%3a%225ec1d8f0-cb62-4000-b327-8e63b0547048%22%2c%22Oid%22%3a%22a202d409-7a31-4076-91b4-f7352fde7396%22%7d tel:+15012443310,,679834925#

S000000203 Page 3 of 11

D. “Requirement” means something required.

E. “Responsive Bid” means a bid submitted in response to this solicitation that conforms in all material respects to this IFB.

F. “Shall” and “Must” mean the imperative and are used to identify requirements.

G. “Specification” means any technical or purchase description or other description of the physical or functional characteristics, or of the nature, of a commodity or service. “Specification” may include a description of any requirement for inspecting, testing, or preparing a commodity or service for delivery.

H. “State” means the State of Arkansas. When the term “State” is used herein to reference any obligation of the State under a contract that results from this solicitation, that obligation is limited to the Department using such a contract.

1.5 BACKGROUND

On July 10, 2014, the ASCL received accreditation through the ASCLD/LAB-International program. This program is based on the ISO/IEC 17025 standards for the competence of testing laboratories, with supplemental requirements based on the needs of the forensic science discipline.

1.6 ESTIMATED QUANTITIES

The quantities listed in ARBuy are estimated for bidding purposes only and may vary according to the needs of ASCL. ASCL reserves the right to increase or decrease the quantities on an as needed basis.

1.7 NEW TOXICOLOGY TESTING KITS

A. The State intends to obtain for the duration of the resultant contract or any contract extensions thereof products that reflect the industry’s latest Drug Testing Qualitative Toxicology Testing Kit technology. The State recognizes that there will be Drug Testing Qualitative Toxicology Kit testing technological modifications and improvements that will become available during the life of this contract that will be unavailable on the date of the contract award.

B. New items, or items not previously tested, must be available to the Arkansas State Crime Laboratory at discounted contract pricing. (e.g., Well plates in a different configuration than identified in this IFB)

C. New well plate items must receive the same pricing parameters as other items listed in this IFB.

D. No penalties will be incurred by the Arkansas State Crime Lab for any returned items.

1.8 PROSPECTIVE CONTRACTOR QUALIFICATIONS

A. Prospective Contractor shall have an accreditation of ISO/IEC 17025 or equivalent to be determined by ASCL.

B. Prospective Contractor should provide, but must be submitted when requested by TSS OSP, a copy of the ISO/IEC 17025 or equivalent accreditation certificate with their Bid Response Packet.

C. Prospective Contractor shall have a minimum of one (1) year experience providing SLE plates for toxicology testing of biological specimens to laboratories located in the continental United States.

D. Prospective Contractor shall be a manufacturer, or an approved distributor, of the brand they intend to provide ASCL.

S000000203 Page 4 of 11

E. ASCL reserves the right to request verification of manufacturer, or an approved distributor, prior to Anticipation to Award.

F. ASCL reserves the right to request references and/or documented proof of experience, prior to Anticipation to Award.

1.9 SPECIFICATIONS FOR WELL PLATE (96 & 48)

A. Contractor shall provide each item as a kit. Components of the kit may vary based on the testing it is employed in. Each kit may include 96 or 48-well plate with calibrators or controls, SLE filtration plates, collection plates, beta-glucuronidase or other equivalent enzyme plates. Also, including any additional materials deemed necessary to perform the toxicology testing.

B. Item #1: 96-well plate with calibrators and controls for quantitative analysis.

1. The 96-well plate must include the following drugs:

6-Monoacetylmorphine Clonazepam Methamphetamine

7-Aminoclonazepam Cocaine Morphine

Acetaminophen Codeine Nordiazepam

Alprazolam Cyclobenzaprine Oxycodone

Amitriptyline Diazepam Oxymorphone

Amphetamine Dihydrocodeine Quetiapine

Benzoylecgonine Diphenhydramine Sertraline

Buprenorphine Fentanyl Tramadol

Bupropion Hydrocodone Trazodone

Caffeine Hydromorphone Zolpidem

Carisoprodol Lorazepam

Citalopram Methadone

2. ASCL reserves the right to restructure the well plate and/or internal standards drugs for Item #1 as needed.

3. Contractor shall make changes to well plate drugs and/or internal standards, based on communications from ASCL, within a fifteen (15) working day notification from ASCL.

4. The calibrators and controls must have a range of 10 – 1000 ng/mL

5. Fentanyl and 6-Monoacetylmorphine must have a range of 1 – 100 ng/mL

6. Carisoprodol must have a range of 100 – 10,000 ng/mL

7. Internal standards for Item #1 must include the following drugs:

6-Monoacetylmorphine-D6 Citalopram-D6 Morphine-D6

7-Aminoclonazepam-D4 Clonazepam-D4 Nordiazepam-D5

7-Aminoflunitrazepam-D7 Cocaine-D3 Oxycodone-D6

Acetaminophen-D4 Codeine-D6 Oxymorphone-D3

Alprazolam-D5 Cyclobenzaprine-D3 Quetiapine-D8

Amitriptyline-D3 Diazepam-D5 Sertraline-D3

Amphetamine-D11 Dihydrocodeine-D6 Tramadol-13C-D3

S000000203 Page 5 of 11

C. Item #2: 48-well plate with calibrators and controls for blood.

1. The 48-well plate must have calibrators and controls for the following drugs:

Δ9-Tetrahydrocannabinol (THC)

11-Nor-9-carboxy-THC (THC-COOH)

11-Hydroxy-Δ9-tetrahydrocannabinol (THC-OH)

2. ASCL reserves the right to restructure the well plate and/or internal standards drugs for Item #2

3. Contractor shall make changes to well plate drugs and/or internal standards, based on communications from ASCL, within a fifteen (15) working day notification from ASCL.

4. The calibrators and controls must have a working range between 1 ng/mL – 500 ng/mL

5. Internal standards for Item #2 must include the following drugs:

THC-D3

THC-COOH-D9

THC-OH-D3

D. Item #3: 96-well plate for screening common drugs of abuse for urine.

1. The 96-well plate must have calibrators and controls for the following drugs:

Cannabidiol (CBD) [Urine plate only]

Δ9-Tetrahydrocannabinol (THC)

11-Nor-9-carboxy-THC (THC-COOH)

11-Hydroxy-Δ9-tetrahydrocannabinol (THC-OH)

2. ASCL reserves the right to restructure the well plate and/or internal standards drugs for Item #3 communications from ASCL, within a fifteen (15) working day notification from ASCL.

4. The calibrators and controls must have a working range between 1 ng/mL – 500 ng/mL

5. Internal standards for Item #3 must include the following drugs:

Cannabidiol-D3 [Urine plate only]

THC-D3

THC-COOH-D9

THC-OH-D3

Benzoylecgonine-D8 Diphenhydramine-D3 Trazodone-D6

Buprenorphine-D4 Fentanyl-D5 Zolpidem-D6

Bupropion-D9 Hydrocodone-D6

Caffeine-13C3 Hydromorphone-D6

Carisoprodol-D7 Methadone-D9

S000000203 Page 6 of 11

E. Item #4: 96-well plate for screening common drugs of abuse for blood.

1. The 96-well plates must be designed to include analytes listed in the table below:

6-MAM Estazolam Naproxen

7-aminoclonazepam Etizolam Nitrazepam

7-aminoflunitrazepam Fentanyl Nordiazepam

Acetaminophen Flunitrazepam Norfluoxetine

Acetyl Fentanyl Fluoxetine Nortriptyline

Alprazolam Flurazepam Ondansetron

Amitriptyline Gabapentin Oxazepam

Amphetamine Haloperidol Oxycodone

Atropine Hydrocodone Oxymorphone

Benzoylecgonine Hydromorphone Phenazepam

Buprenorphine Hydroxyzine Phencyclidine

Bupropion Ibuprofen Phentermine

Butabarbital Imipramine Phenytoin

Carbamazepine Levamisole Promethazine

Carisoprodol Loratidine Propoxyphene

Cetirizine Lorazepam Quetiapine

Chlordiazepoxide MDA Sertraline

Citalopram MDMA Tapentadol

Clonazepam Meperidine Temazepam

Cocaine Meprobamate THC

Codeine Methadone THC-COOH

Cyclobenzaprine Methamphetamine THC-OH

Desipramine Methylphenidate Tramadol

Dextromethorphan Metoprolol Trazodone

Diazepam Midazolam Valproic Acid

Dihydrocodeine Mirtazapine Venlafaxine

Diphenhydramine Mitragynine Zolpidem

Doxepin Morphine

Doxylamine Naloxone

2. ASCL reserves the right to restructure the well plate and/or internal standards drugs for common drugs of abuse as needed.

communications from ASCL, within a fifteen (15) business day notification from ASCL.

4. Contractor shall incorporate deuterated internal standards corresponding to individual analytes specified in the table above with the exceptions noted below:

a. Should no suitable corresponding internal standard be available, appropriate surrogate internal standards must be discussed with ASCL prior to plate manufacture.

5. Contractor shall notify ASCL fifteen (15) working days prior to order shipment, of any of the corresponding internal standards, not included in the individual analytes as specified in the table above.

S000000203 Page 7 of 11

F. Item #5: 96-well plate for screening common drugs of abuse for urine.

1. The 96-well plates must be designed to include analytes listed in the table below:

6-MAM Estazolam Naproxen

7-aminoclonazepam Etizolam Nitrazepam

7-aminoflunitrazepam Fentanyl Nordiazepam

Acetaminophen Flunitrazepam Norfluoxetine

Acetyl Fentanyl Fluoxetine Nortriptyline

Alprazolam Flurazepam Ondansetron

Amitriptyline Gabapentin Oxazepam

Amphetamine Haloperidol Oxycodone

Atropine Hydrocodone Oxymorphone

Benzoylecgonine Hydromorphone Phenazepam

Buprenorphine Hydroxyzine Phencyclidine

Bupropion Ibuprofen Phentermine

Butabarbital Imipramine Phenytoin

Carbamazepine Levamisole Promethazine

Carisoprodol Loratidine Propoxyphene

Cetirizine Lorazepam Quetiapine

Chlordiazepoxide MDA Sertraline

Citalopram MDMA Tapentadol

Clonazepam Meperidine Temazepam

Cocaine Meprobamate THC

Codeine Methadone THC-COOH

Cyclobenzaprine Methamphetamine THC-OH

Desipramine Methylphenidate Tramadol

Dextromethorphan Metoprolol Trazodone

Diazepam Midazolam Valproic Acid

Dihydrocodeine Mirtazapine Venlafaxine

Diphenhydramine Mitragynine Zolpidem

Doxepin Morphine

Doxylamine Naloxone

2. ASCL reserves the right to restructure the well plate and/or internal standards drugs for common drugs of abuse as needed.

3. Contractor shall make changes to well plate drugs and/or internal standards, based on communications from ASCL, within a fifteen (15) business day notification from ASCL.

4. Contractor shall incorporate deuterated internal standards corresponding to individual analytes specified in the table above with the exceptions noted below:

a. Should no suitable corresponding internal standard be available, appropriate surrogate internal standards must be discussed with ASCL prior to plate manufacture.

S000000203 Page 8 of 11

5. Contractor shall notify ASCL fifteen (15) working days prior to order shipment, of any of the corresponding internal standards, not included in the individual analytes as specified in the table above.

G. Sample preparation plate, Isolute SLE+plate, ß-glucuronidase plate, for respective urine assays and collection plate must be included.

1. Analysis plates must include but not be limited to the following:

a. Be pre-manufactured and sealed.

b. Be packaged to minimize damage during shipping and storage.

c. Have a minimum shelf life of six (6) months without any degradation under frozen conditions.

2. Sample preparation plates must include but not limited to the following:

a. Multi-analyte mixtures of NIST traceable certified reference standards relevant to the methods of analyses listed in this IFB.

b. Sample preparation plates must be manufactured with:

i. Calibrators

ii. Wherever applicable, quality control materials should be provided from a secondary source, prepared, and analyzed with the samples.

iii. Internal standards at precise concentrations allowed for simple and consistent sample preparation.

3. Certificates of analysis of analytes must be included with delivery of the sample preparation plates.

H. Validation plates and individual stock solutions of calibrators associated with validation plates.

1. Validation plates will be ordered whenever the need arises for the development of new analytical methods. The analytes included and their associated ranges will be discussed between the manufacturer and the ASCL before procurement.

1.10 DELIVERY REQUIREMENTS

A. The Contractor shall provide all transportation expenses for the Toxicology Kits, which includes, FOB Destination, Freight/Shipping Paid.

B. ASCL requests delivery within thirty (30) Business Days after receipt of order.

1. If this delivery date cannot be met, the Contractor shall state in the Bid Response Packet the alternate number of days required to place the commodity in the designated location as specified in Section 1.11.

2. Failure to state the alternate delivery date in the Bid Response Packet obligates the Contractor to complete delivery by ASCL’s requested date. Extended delivery dates may be considered when in the best interest of the State.

C. All deliveries must be made during normal State Business hours and within the agreed upon number of days unless otherwise arranged and coordinated with ASCL.

S000000203 Page 9 of 11

D. The Contractor shall immediately notify ASCL of any anticipated delays or plant shutdowns that will affect the delivery requirement.

E. The Contractor shall be responsible for loss or damage that occurs during shipping, prior to the order being received by ASCL.

F. The Contractor shall properly package the Toxicology Kits to prevent damage during shipping.

G. The State assumes no liability for commodities produced, processed, or shipped in excess of the amount specified on ASCL’s purchase order.

1.11 DELIVERY: FOB DESTINATION

Arkansas State Crime Lab Attention: Kristen Mauldin #3 Natural Resource Drive Little Rock, AR 72205

1.12 ACCEPTANCE STANDARDS

A. ASCL will inspect and accept or reject the products within thirty (30) days of receipt.

B. ASCL has the option to return any products within the thirty (30) day timeframe for any reason.

C. The Prospective Contractors bid must include a “total satisfaction” return policy for all products and must not impose any liability on the State for such returns.

S000000203 Page 10 of 11

SECTION 2 – GENERAL INSTRUCTIONS AND INFORMATION

• Do not provide responses to items in this section unless specifically and expressly required.

2.1 TYPE OF CONTRACT

A. As a result of this IFB, TSS OSP intends to award a one-year Term contract to a single Contractor.

B. The anticipated starting date for any resulting contract is February 6, 2023, except that the actual contract start date may be adjusted unilaterally by the State for up to three (3) calendar months. By submitting a signed bid in response to the IFB, the Prospective Contractor represents and warrants that it will honor its bid as being held open as irrevocable for this period.

2.2 CONTRACTOR SELECTION

A. Award will be made to the lowest-bidding, responsible Prospective Contractor on an all or none total basis.

B. TSS OSP and/or ASCL reserves the right to request additional documentation from the Prospective Contractor at any time to complete the review of the Prospective Contractor’s bid submission.

Requested documentation must be received by TSS OSP within (72) hours of written or verbal request.

2.3 RESPONSE DOCUMENTS

A. All bid responses must be submitted through ARBuy, the State’s eProcurement system. The system can be accessed at https://arbuy.arkansas.gov.

B. Bid Response Packet

1. The following are bid submission requirements and must be submitted as part of a Prospective

Contractor’s bid response.

a. Signed Bid Signature Page. Signature may be ink or digital. (See Bid Response Packet.)

b. Completed Bid Response Packet, which must be in the English language.

c. Completed Pricing Response submitted in ARBuy. Pricing must be proposed in U.S. dollars and cents.

d. Proposed Subcontractors Form. The utilization of any proposed subcontractor is subject to approval by the Department.

e. Exceptions Form.

f. Copy of Prospective Contractor’s Equal Opportunity Policy.

2. The following items, which must be submitted prior to a contract award to the Prospective Contractor, may also be included with the Prospective Contractor’s bid response:

a. EO 98-04 Contract & Grant Disclosure Form.

b. ISO/IEC 17025 or equivalent accreditation certificate

3. DO NOT include any other documents or ancillary information, such as a cover letter or promotional/marketing information.

2.4 ACCEPTANCE OF REQUIREMENTS

A. Unless a Prospective Contractor expressly and conspicuously identifies any exception or exceptions to any of the Requirements in the Requirements Section(s) of this IFB by listing them on the Exceptions Form (See Bid Response Packet), Prospective Contractor understands and agrees its submission of a bid to represent that its bid meets all such Requirements.

https://arbuy.arkansas.gov/

S000000203 Page 11 of 11

B. A Prospective Contractor’s bid may be rejected if the Prospective Contractor takes exception to any

Requirements in the Requirements Section(s) of this IFB.

2.5 ADDITIONAL TERMS AND CONDITIONS

A. This IFB incorporates all of the Solicitation Terms and Conditions located on the TSS OSP website here (Agencies – Forms and Reporting – Solicitation Templates):

https://www.transform.ar.gov/procurement/agencies/forms-and-reporting/.

B. Any special terms and conditions included in this solicitation shall override the Solicitation Terms and Conditions.

C. Unless a Prospective Contractor expressly and conspicuously identifies any exception or exceptions to any of the terms in the Standard Commodities Contract by listing them on the Exceptions Form (See Bid Response Packet), Prospective Contractor agrees and shall adhere to all terms if selected as the successful Contractor. Items identified as non-negotiable may only be modified if the legal requirement is satisfied and approved by the State. The Standard Commodities Contract can be viewed on the TSS OSP website here (Agencies – Forms and Reporting – Solicitation Templates):

https://www.transform.ar.gov/procurement/agencies/forms-and-reporting/.

D. A Prospective Contractor’s bid may be rejected if a Prospective Contractor takes exception to any terms or conditions in the documents listed in 2.5.A and 2.5.C.

2.6 PRICING

A. Prospective Contractor shall enter pricing for all items in the ARBuy e-Procurement portal only.

B. Prospective Contractor shall include all costs in their bid price, excluding taxes, that is associated with fulfilling the Requirements of this IFB including but not limited to the following:

1. FOB Destination, shipping/freight and handling cost paid.

2. Product Data Specification Sheets.

C. If any cost is not identified by the successful Contractor but is subsequently incurred to achieve successful operation, the Contractor shall bear this additional cost.

D. DO NOT submit any ancillary information not related to actual pricing.

2.7 PRICE ESCALATION

A. Price changes may be negotiated at the discretion of the State. Any request for a price increase must include supporting documentation demonstrating that the increase in contract price is based on an increased cost to the Contractor and that the proposed pricing is still competitive in the marketplace.

ASCL and/or TSS OSP, has the right to approve or deny any request for a price adjustment.

B. In the event of a general price decrease, the State shall be guaranteed full benefit of the price reduction for all undelivered purchase orders on the effective date of the decrease and thereafter.

https://www.transform.ar.gov/procurement/agencies/forms-and-reporting/ https://www.transform.ar.gov/procurement/agencies/forms-and-reporting/